Pfizer

On Thursday, Cathie Wood-led Ark Invest made a significant move by offloading shares of Moderna Inc (NASDAQ:MRNA). This decision comes amidst a backdrop of mixed analyst sentiments and Moderna’s recently unveiled post-COVID roadmap. The Moderna Trade Ark Invest’s ARK Genomic Revolution...

Pfizer Inc. (NYSE:PFE) has launched a multi-year cost-cutting initiative aimed at saving approximately $1.5 billion by the end of 2027. What Happened: The new program builds on a $4 billion cost reduction plan announced last year, Reuters reported on Thursday. This move comes as the company faces...

An 18-month-old British child has regained her hearing through a pioneering gene therapy, marking a significant stride in the treatment of deafness. What Happened: Opal Sandy, who was born with a rare genetic condition that left her completely deaf, has now been able to hear without the need for...

Wednesday saw a mixed performance in major U.S. indices. The Dow Jones Industrial Average closed the day with a 0.2% increase at 37,903.29, while the S&P 500 finished lower by 0.3% at 5,018.39. Similarly, the Nasdaq ended the day down 0.33% at 15,605.48. These are the top stocks that gained the...

The Centers for Disease Control and Prevention (CDC) has recommended a second annual COVID-19 vaccine for individuals aged 65 and above. This decision comes in the wake of a significant increase in COVID-19 hospitalizations among older Americans. What Happened: The CDC’s Advisory Committee...

Pfizer Inc (NYSE:PFE) has agreed to pay $93 million to settle an antitrust lawsuit related to its cholesterol drug Lipitor. What Happened: The lawsuit, filed by wholesale drug distributors, accused Pfizer of colluding with India’s Ranbaxy Laboratories to delay the sale of cheaper, generic...

The stock market witnessed a notable surge today, with the Dow Jones rising 0.43% to 37,248.35 and the S&P 500 gaining 0.26% to 4,719.55. The Nasdaq also ended Thursday in the green appreciating 0.19% to 14,761.56. Transitioning from the broader market, we now turn our focus to individual...

Major U.S. indices were in the green on Wednesday with the Dow Jones rising 1.4% to 37,090.24, the S&P 500 gaining 1.37% to 4,707.09 and the tech-heavy Nasdaq appreciating 1.38% to 14,733.96. On the same day, Federal Reserve Chair Jerome Powell signaled a peak in interest rates and foresaw cuts...

According to an Associated Press report, the Israel-Hamas conflict has stirred up controversy within the global business sector. High-ranking executives and ordinary workers alike are grappling with the repercussions of voicing their opinions on the issue. The CEO of Pfizer Inc., Albert Bourla...

U.S. stocks showcased a positive momentum as the trading day approached its end. The Nasdaq Composite exhibited a notable rise, gaining more than 1% on Monday. The tech-heavy index closed at 13,917.89 for the day. The Dow Jones Industrial Average also reflected an upward trend, increasing by 0.25%...

U.S. stocks experienced a downward trend midway through trading, with the Dow Jones declining approximately 200 points on Wednesday. The Dow ended Wednesday lower by 0.57% to 34,443.19, while the NASDAQ saw a decrease of 1.06% to 13,872.47. Similarly, the S&P 500 also witnessed a drop, falling...

On Tuesday, the European Union’s drug regulator expanded its investigation into the risk of suicidal thoughts and self-injury among patients taking weight loss and diabetes medications, including those produced by Novo Nordisk (NASDAQ:NVO). The probe now encompasses about 150 reported cases...

Zoetis (NYSE: ZTS) shareholders may have a new reference point to be excited about, even after witnessing some favorable developments through the company's first quarter 2023 announcements. Even after outperforming other peers in the sector, such as Bausch Health Companies (NYSE...

By StoryTrading Pfizer collaboration just revealed in presentation update - no PR issued yet! – Several near-term catalysts possible, including further partnerships with big pharma – Sentiment: CEO’s credibility hit from under-delivering now turning around  –...

Benzinga has examined the prospects for many investor favorite stocks over the past week. Last week's bullish calls included a FAANG stock and a COVID-19 vaccine maker. A fintech giant and a meme stock were among the bearish calls seen. The new earnings-reporting season began this past...